AVITA Medical (RCEL) Net Cash Flow (2019 - 2025)

AVITA Medical's Net Cash Flow history runs 7 years deep, the most recent figure standing at -$5.2 million for Q4 2025.

• Quarterly Net Cash Flow fell 12.86% year-over-year to -$5.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.8 million (up 52.81% YoY) and the FY2025 annual result came in at -$3.8 million, up 52.81% from the prior year.
• Net Cash Flow was -$5.2 million for Q4 2025 at AVITA Medical, down from $3.2 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $55.1 million in Q1 2021 and bottomed at -$64.0 million in Q2 2022.
• A 5-year average of -$4.1 million and a median of -$53000.0 in 2022 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2021 — Net Cash Flow jumped 822.38% — and 2023, when it slumped 4633.94%.
• AVITA Medical's Net Cash Flow stood at $750000.0 in 2021, then sank by 180.93% to -$607000.0 in 2022, then slumped by 4633.94% to -$28.7 million in 2023, then surged by 84.03% to -$4.6 million in 2024, then fell by 12.86% to -$5.2 million in 2025.
• Business Quant data shows RCEL's Net Cash Flow at -$5.2 million in Q4 2025, $3.2 million in Q3 2025, and -$2.7 million in Q2 2025.